Medication Therapy Management and Optimization
Medication therapy management and optimization is the area of pharmacy practice concerned with reviewing a patient's complete medication regimen, identifying and resolving drug therapy problems, and refining therapy so that medicines are indicated, effective, safe, and able to be taken as intended. It encompasses structured services such as medication therapy management (MTM) as well as the broader discipline of pharmaceutical care that frames the pharmacist's responsibility for medication-related outcomes.
Definition
Medication therapy management and optimization refers to the systematic evaluation and refinement of a patient's medications, carried out to ensure each drug is appropriately indicated, effective, safe, and convenient, and to detect, resolve, and prevent drug therapy problems.
Scope
The area orients readers to the conceptual basis of pharmaceutical care and to the main domains of medication optimization: the delivery of structured MTM services, systematic regimen review, deprescribing of unnecessary or harmful medicines, and tailoring of therapy in populations with altered pharmacokinetics or heightened risk. It is a reference overview of how medication review is organized as a professional activity, not clinical guidance for any individual regimen.
Sub-topics
Key concepts
- Drug therapy problem
- Comprehensive medication review
- Medication reconciliation
- Indication, effectiveness, safety, and adherence
- Comprehensive medication management
- Pharmacist-led intervention
Key theories
- Pharmaceutical care
- Hepler and Strand framed pharmaceutical care as the responsible provision of drug therapy to achieve definite outcomes that improve a patient's quality of life, shifting the pharmacist's role from product dispensing toward accountability for medication-related outcomes; this conceptual model underpins MTM and comprehensive medication management.
Clinical relevance
Medication optimization is associated with the detection and resolution of drug-related problems and is a recognized component of multidisciplinary care for patients on multiple medicines. This entry describes how such services are conceived and organized as a field of practice and does not provide individualized treatment, dosing, or deprescribing advice.
Epidemiology
The relevance of the area grows with polypharmacy and an ageing population, since the number of medicines a person takes is a principal driver of drug interactions, adverse drug events, and non-adherence; observational work links clinical pharmacy services to medication-related outcomes at population and institutional levels.
Evidence & guidelines
Evidence in this area ranges from the foundational conceptual literature on pharmaceutical care to observational evaluations of MTM and clinical pharmacy services and to consensus criteria for appropriate prescribing in older adults. Service definitions, eligibility, and documentation standards are set largely by professional bodies and payers rather than by trial evidence alone.
History
The modern framing of the area dates to Hepler and Strand's 1990 articulation of pharmaceutical care, which recast the pharmacist's mission around responsibility for therapeutic outcomes. Over the following decades this concept was operationalized as structured MTM services and as comprehensive medication management, supported by evaluations such as the Minnesota MTM experience.
Key figures
- Charles Hepler
- Linda Strand
- Robert Cipolle
Related topics
Seminal works
- hepler-strand-1990
- isetts-2008
- cipolle-2012
Frequently asked questions
- What is the difference between medication therapy management and medication optimization?
- Medication therapy management (MTM) usually denotes a defined, often reimbursable service with specified components, whereas medication optimization is the broader goal of making a regimen as indicated, effective, safe, and adherence-friendly as possible; MTM is one structured vehicle for pursuing that goal.
- How does pharmaceutical care relate to this area?
- Pharmaceutical care is the conceptual foundation: it defines the pharmacist's responsibility for medication outcomes, and MTM, regimen review, deprescribing, and tailoring of therapy in special populations are the activities through which that responsibility is exercised.